SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VD's Model Portfolio & Discussion Thread

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Pseudo Biologist who wrote (2432)9/16/1997 3:13:00 AM
From: Vector1   of 9719
 
Soliciting views on Molecular Dynamics. I think I want to add them to the portfolio but I want opinions. this is a pick and shovel company. Thier MegaBACE 100 Sequencer is getting rave reviews. It is being presented at the International Genome Sequencing and Analysis Conference in Hilton Head and is purported to be 5 times faster than competitive sequencers. The technology which is a partership with Ampersham relies on capillary electrophoresis. the capillary system allows sequencing to be conducted in a series of polymer containing narrow tubes instead of a slab gel. MegaBAC cansequence an estimated 600 bases per capillary in 70 minutes.
This is a substantial and gowing market. the total market cap is $250 million and the market for high throuput DNA sequencing is estimated to be about $400 million and growing at 20% a year.
V1
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext